Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

Similar articles for PubMed (Select 21098252)


A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.

Pastagia M, Euler C, Chahales P, Fuentes-Duculan J, Krueger JG, Fischetti VA.

Antimicrob Agents Chemother. 2011 Feb;55(2):738-44. doi: 10.1128/AAC.00890-10. Epub 2010 Nov 22.


Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA.

Antimicrob Agents Chemother. 2010 Apr;54(4):1603-12. doi: 10.1128/AAC.01625-09. Epub 2010 Jan 19.


The persistence of Staphylococcus aureus decolonization after mupirocin and topical chlorhexidine: implications for patients requiring multiple or delayed procedures.

Immerman I, Ramos NL, Katz GM, Hutzler LH, Phillips MS, Bosco JA 3rd.

J Arthroplasty. 2012 Jun;27(6):870-6. doi: 10.1016/j.arth.2012.01.010. Epub 2012 Mar 6.


In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.

Rouse MS, Rotger M, Piper KE, Steckelberg JM, Scholz M, Andrews J, Patel R.

Antimicrob Agents Chemother. 2005 Aug;49(8):3187-91.


Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections.

Miller LG, Tan J, Eells SJ, Benitez E, Radner AB.

Antimicrob Agents Chemother. 2012 Feb;56(2):1084-6. doi: 10.1128/AAC.01608-10. Epub 2011 Nov 14.


Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.

Fritz SA, Hogan PG, Camins BC, Ainsworth AJ, Patrick C, Martin MS, Krauss MJ, Rodriguez M, Burnham CA.

Antimicrob Agents Chemother. 2013 Jan;57(1):559-68. doi: 10.1128/AAC.01633-12. Epub 2012 Nov 12.


Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

McNeil JC, Hulten KG, Kaplan SL, Mason EO.

Antimicrob Agents Chemother. 2011 May;55(5):2431-3. doi: 10.1128/AAC.01587-10. Epub 2011 Jan 31.


Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.

Vingsbo Lundberg C, Frimodt-Møller N.

Int J Antimicrob Agents. 2013 Sep;42(3):272-5. doi: 10.1016/j.ijantimicag.2013.05.008. Epub 2013 Jul 6.


Agents for the decolonization of methicillin-resistant Staphylococcus aureus.

McConeghy KW, Mikolich DJ, LaPlante KL.

Pharmacotherapy. 2009 Mar;29(3):263-80. doi: 10.1592/phco.29.3.263. Review.


Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections.

Cho JS, Zussman J, Donegan NP, Ramos RI, Garcia NC, Uslan DZ, Iwakura Y, Simon SI, Cheung AL, Modlin RL, Kim J, Miller LS.

J Invest Dermatol. 2011 Apr;131(4):907-15. doi: 10.1038/jid.2010.417. Epub 2010 Dec 30.


LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.

Gu J, Xu W, Lei L, Huang J, Feng X, Sun C, Du C, Zuo J, Li Y, Du T, Li L, Han W.

J Clin Microbiol. 2011 Jan;49(1):111-7. doi: 10.1128/JCM.01144-10. Epub 2010 Nov 3.


Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections.

Fernandez J, Hilliard JJ, Morrow BJ, Melton JL, Flamm RK, Barron AM, Lynch AS.

Antimicrob Agents Chemother. 2011 Dec;55(12):5522-8. doi: 10.1128/AAC.00471-11. Epub 2011 Sep 12.


Antistaphylococcal activity of bacteriophage derived chimeric protein P128.

Vipra AA, Desai SN, Roy P, Patil R, Raj JM, Narasimhaswamy N, Paul VD, Chikkamadaiah R, Sriram B.

BMC Microbiol. 2012 Mar 22;12:41. doi: 10.1186/1471-2180-12-41.


Squalamine ointment for Staphylococcus aureus skin decolonization in a mouse model.

Djouhri-Bouktab L, Alhanout K, Andrieu V, Raoult D, Rolain JM, Brunel JM.

J Antimicrob Chemother. 2011 Jun;66(6):1306-10. doi: 10.1093/jac/dkr114. Epub 2011 Mar 29.


Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin.

Maraha B, van Halteren J, Verzijl JM, Wintermans RG, Buiting AG.

Clin Microbiol Infect. 2002 Oct;8(10):671-5.


Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.

Semret M, Miller MA.

Infect Control Hosp Epidemiol. 2001 Sep;22(9):578-80.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk